Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

2.7K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.7K
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

2.3K
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
2.3K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

2.6K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.6K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

1.6K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suitability of Estimated Glomerular Filtration Rate for Live Kidney Donor Selection.

Transplantation proceedings·2018
Same author

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.

Kidney international·2007
Same author

New aspects of posttransplant nephrotic syndrome: clinicopathologic correlations with outcomes.

Transplantation proceedings·2004
Same author

Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.

Human pathology·2001
Same author

Renal cell apoptosis in chronic obstructive uropathy: the roles of caspases.

Kidney international·2001
Same author

Guidelines for the referral and management of patients eligible for solid organ transplantation.

Transplantation·2001
Same journal

Proceedings of the 9th International Congress on Renal Nutrition and Metabolism. Vienna, Austria. August 29-September 1, 1998.

Mineral and electrolyte metabolism·2000
Same journal

Bioelectrical impedance analysis in dialysis patients.

Mineral and electrolyte metabolism·2000
Same journal

Nutritional status assessment and body composition analysis in pre-end stage renal disease patients.

Mineral and electrolyte metabolism·2000
Same journal

Long, slow dialysis.

Mineral and electrolyte metabolism·2000
Same journal

Nitric oxide/L-arginine in uremia.

Mineral and electrolyte metabolism·2000
Same journal

Advanced glycation end-product levels in subtotally nephrectomized rats: beneficial effects of angiotensin II receptor 1 antagonist losartan.

Mineral and electrolyte metabolism·2000
See all related articles

Related Experiment Video

Updated: May 1, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

12.8K

Diuretic resistance.

W N Suki1

  • 1Renal Section, Department of Medicine, Baylor College of Medicine, Houston, Tex., USA. wsuki@bcm.tmc.edu

Mineral and Electrolyte Metabolism
|April 20, 1999
PubMed
Summary
This summary is machine-generated.

Diuretic resistance is common but manageable by optimizing drug and patient factors. Strategies involve adjusting doses, administration, and drug combinations to enhance diuretic effectiveness, even in difficult cases.

More Related Videos

Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice
08:15

Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice

Published on: September 17, 2015

18.9K
Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
12:37

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

12.5K

Related Experiment Videos

Last Updated: May 1, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

12.8K
Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice
08:15

Cardiac Pressure-Volume Loop Analysis Using Conductance Catheters in Mice

Published on: September 17, 2015

18.9K
Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
12:37

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine

Published on: February 9, 2016

12.5K

Area of Science:

  • Nephrology
  • Clinical Pharmacology

Background:

  • Diuretic resistance is a frequent clinical challenge impacting patient outcomes.
  • Understanding the interplay of pharmacodynamic and pharmacokinetic factors is crucial for effective management.

Purpose of the Study:

  • To outline systematic strategies for optimizing diuretic therapy in resistant cases.
  • To detail pharmacodynamic and pharmacokinetic adjustments to improve diuretic efficacy.

Main Methods:

  • Optimizing underlying disease state and managing salt intake.
  • Adjusting diuretic dosing, administration frequency, and drug bioavailability.
  • Utilizing drug combinations targeting different parts of the nephron.

Main Results:

  • Pharmacodynamic optimization includes disease management and avoiding hypotensive agents.
  • Pharmacokinetic optimization involves appropriate dosing, continuous infusion, and enhancing drug bioavailability.
  • Combination therapy across nephron segments typically overcomes resistance.

Conclusions:

  • Systematic optimization of pharmacodynamic and pharmacokinetic factors is key to managing diuretic resistance.
  • Combination diuretic therapy offers a robust approach for refractory cases.